Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - authors' reply by Nazarzadeh, M, Adler, AI, Chalmers, J, Holman, RR, Rahimi, K

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89 by Wamil, M, Coleman, RL, Adler, AI, McMurray, JJV, Holman, RR

Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91) by Adler, AI, Coleman, RL, Leal, J, Whiteley, WN, Clarke, P, Holman, RR

An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders by De Giorgi, R, Ghenciulescu, A, Dziwisz, O, Taquet, M, Adler, AI, Koychev, I, Upthegrove, R, Solmi, M, McCutcheon, R, Pillinger, T, Cowen, PJ, Harmer, CJ

Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study by Bidulka, P, O'Neill, S, Basu, A, Wilkinson, S, Silverwood, RJ, Charlton, P, Briggs, A, Adler, AI, Khunti, K, Tomlinson, LA, Smeeth, L, Douglas, IJ, Grieve, R

Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults by Koychev, I, Adler, AI, Edison, P, Tom, B, Milton, JE, Butchart, J, Hampshire, A, Marshall, C, Coulthard, E, Zetterberg, H, Hellyer, P, Cormack, F, Underwood, BR, Mummery, CJ, Holman, RR

Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data by Bidulka, P, Lugo-Palacios, DG, Carroll, O, O’Neill, S, Adler, AI, Basu, A, Silverwood, RJ, Bartlett, JW, Nitsch, D, Charlton, P, Briggs, AH, Smeeth, L, Douglas, IJ, Khunti, K, Grieve, R

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis by Nazarzadeh, M, Bidel, Z, Canoy, D, Copland, E, Bennett, DA, Dehghan, A, Davey Smith, G, Holman, RR, Woodward, M, Gupta, A, Adler, AI, Wamil, M, Sattar, N, Cushman, WC, McManus, RJ, Teo, K, Davis, BR, Chalmers, J, Pepine, CJ, Rahimi, K